Datametrex AI Limited (DTMXF) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Datametrex AI Limited (DTMXF), Technology sektöründe faaliyet gösteriyor, son olarak $'dan işlem görüyor ve 0 piyasa değerine sahip. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 39/100 (ihtiyatlı) olarak derecelendirilmiştir.
Son analiz: 17 Mar 2026Datametrex AI Limited (DTMXF) Teknoloji Profili ve Rekabetçi Konumu
Datametrex AI Limited provides AI-powered data analytics and health security solutions, operating primarily in Canada and South Korea. The company leverages machine learning for data collection, analysis, and presentation, serving industries through its AI and Technology, and Health Security segments. It faces competition in the rapidly evolving AI and health tech landscape.
Yatırım Tezi
Datametrex AI Limited presents a speculative investment opportunity within the AI and health security sectors. The company's negative profit margin of -114.8% indicates it is not currently profitable. Revenue growth and market expansion, particularly in the health security segment, are key value drivers. Successful adoption of its Medi-Call app and NexaSecurity platform could drive future growth. However, the company's small market capitalization and OTC listing introduce significant risk. The investment thesis hinges on Datametrex's ability to scale its AI solutions and achieve profitability in a competitive market. Investors should closely monitor financial performance and market traction.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Market capitalization of $0.00B indicates a micro-cap company with high growth potential but also significant risk.
- Negative P/E ratio of -0.74 reflects current unprofitability, requiring careful monitoring of future earnings.
- Gross margin of -13.4% suggests challenges in cost management and pricing strategy.
- Beta of 1.26 indicates higher volatility compared to the market, appealing to risk-tolerant investors.
- Operations in both Canada and South Korea provide geographic diversification and exposure to different market dynamics.
Rakipler & Benzerleri
Güçlü Yönler
- Patented AI technology provides a competitive edge.
- Diversified service offerings across AI, technology, and health security.
- Presence in both Canada and South Korea offers geographic diversification.
- Proprietary NexaSecurity platform provides specialized social media monitoring capabilities.
Zayıflıklar
- Negative profit margin indicates financial instability.
- Small market capitalization increases volatility and risk.
- Reliance on COVID-19 related services may decline as the pandemic subsides.
- Limited brand recognition compared to larger competitors.
Katalizörler
- Upcoming: Potential partnerships with healthcare providers to expand Medi-Call adoption.
- Ongoing: Increasing demand for AI-driven data analytics solutions in various sectors.
- Ongoing: Expansion of NexaSecurity platform to new industries and clients.
Riskler
- Potential: Intense competition from larger AI and IT service providers.
- Potential: Rapid technological advancements may render existing solutions obsolete.
- Ongoing: Negative profit margin indicates financial instability.
- Ongoing: OTC listing and small market capitalization increase volatility and risk.
- Potential: Regulatory changes in the healthcare and data privacy sectors.
Büyüme Fırsatları
- Expansion of Medi-Call App: The Medi-Call health app represents a significant growth opportunity for Datametrex. As telemedicine gains wider acceptance, the company can leverage this platform to connect more patients with doctors, offering subscription-based e-health services. The global telemedicine market is projected to reach $431.82 billion by 2030, growing at a CAGR of 25.9% from 2023. Successful marketing and adoption of Medi-Call could drive recurring revenue and establish Datametrex as a key player in the digital health space.
- NexaSecurity Platform Adoption: Datametrex's NexaSecurity platform offers social media discovery and monitoring capabilities. With increasing concerns about online security and misinformation, demand for social media monitoring tools is growing. The social media analytics market is expected to reach $16.55 billion by 2030, growing at a CAGR of 17.2%. By enhancing the platform's features and targeting specific industries, Datametrex can capitalize on this trend and generate revenue through subscriptions and customized solutions.
- AI-Driven Data Analytics Services: Datametrex's core strength lies in its AI-driven data analytics capabilities. As businesses generate vast amounts of data, the need for AI-powered solutions to extract insights and improve decision-making is increasing. The global big data and analytics market is projected to reach $549.7 billion by 2028, growing at a CAGR of 13.2%. Datametrex can focus on specific sectors, such as healthcare and finance, to provide tailored data analytics services and secure long-term contracts.
- Strategic Partnerships: Forming strategic partnerships with established companies in the technology and healthcare sectors can accelerate Datametrex's growth. Collaborating with larger firms can provide access to new markets, technologies, and customer bases. For example, partnering with a major hospital network could facilitate the adoption of Medi-Call and other health security services. These partnerships can enhance Datametrex's credibility and expand its reach.
- Geographic Expansion: While Datametrex currently operates in Canada and South Korea, expanding into new geographic markets represents a significant growth opportunity. Targeting regions with high demand for AI solutions and telemedicine services can diversify revenue streams and reduce reliance on existing markets. Conducting market research and establishing local partnerships are crucial for successful geographic expansion. This could include entering the US or European markets.
Fırsatlar
- Expansion of telemedicine services through the Medi-Call app.
- Growing demand for AI-driven data analytics solutions.
- Strategic partnerships with established companies in the technology and healthcare sectors.
- Geographic expansion into new markets with high demand for AI and telemedicine.
Tehditler
- Intense competition from larger and better-funded AI and IT service providers.
- Rapid technological advancements may render existing solutions obsolete.
- Regulatory changes in the healthcare and data privacy sectors.
- Economic downturns may reduce demand for AI and technology services.
Rekabet Avantajları
- Patented machine learning and artificial intelligence technology.
- Diversified service portfolio across AI, technology, and health security.
- Established presence in both Canada and South Korea.
- Proprietary NexaSecurity social media monitoring platform.
DTMXF Hakkında
Datametrex AI Limited, headquartered in Toronto, Canada, specializes in collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence. The company was founded to leverage AI for diverse applications, evolving into two primary segments: AI and Technology, and Health Security. The AI and Technology segment focuses on providing big data analytics and system integration services. The Health Security segment offers COVID-19 related services, concierge medical services, and telemedicine solutions. Datametrex offers a range of products including NexaSecurity, a social media monitoring platform, and Medi-Call, a health app connecting patients with doctors for e-health services. The company also sells COVID-19 test kits. Datametrex operates primarily in Canada and South Korea, aiming to expand its AI-driven solutions across various sectors. Its competitive positioning relies on patented AI technology and a diversified service portfolio, addressing both technological and health-related needs.
Ne Yaparlar
- Collects and analyzes structured and unstructured data.
- Develops and applies machine learning and artificial intelligence solutions.
- Offers health security services, including COVID-19 related services.
- Provides concierge medical services and telemedicine solutions.
- Sells COVID-19 test kits.
- Offers NexaSecurity, a social-media discovery and monitoring platform.
- Provides Medi-Call health app, connecting patients with doctors.
İş Modeli
- Provides AI and Technology solutions, generating revenue through contracts and service fees.
- Offers Health Security services, earning revenue through service fees and product sales.
- Sells subscriptions to the Medi-Call health app.
- Generates revenue from the NexaSecurity platform through subscriptions and customized solutions.
Sektör Bağlamı
Datametrex AI Limited operates within the rapidly evolving AI and information technology services industry. The market is characterized by increasing demand for data analytics, machine learning solutions, and telemedicine services. Competition includes established IT service providers and specialized AI firms. Datametrex's focus on both AI and health security positions it uniquely, but it faces challenges in scaling and competing with larger, better-funded players. The industry is driven by technological advancements, regulatory changes, and the increasing adoption of digital health solutions.
Kilit Müşteriler
- Businesses seeking AI-driven data analytics solutions.
- Healthcare providers and patients utilizing telemedicine services.
- Organizations requiring social media monitoring and security solutions.
- Government agencies needing data analysis and security services.
Finansallar
Grafik & Bilgi
Datametrex AI Limited (DTMXF) hisse senedi fiyatı: Price data unavailable
Son Haberler
-
Datametrex Subsidiary PayMetrex Highlights Strategic Relevance of Patent Portfolio to Rapidly Expanding SoftPOS Market
accessnewswire.com · 19 Mar 2026
-
Datametrex Integrates AI to Healthcare To Enhance Efficiencies
accessnewswire.com · 10 Mar 2026
-
Paymetrex Engages Pelent AI to Accelerate Patent Licensing Program
accessnewswire.com · 23 Şub 2026
-
Datametrex Receives $1M Order from Fortune 500 Client
accessnewswire.com · 18 Şub 2026
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
DTMXF için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
DTMXF için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, DTMXF'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Son Haberler
Datametrex Subsidiary PayMetrex Highlights Strategic Relevance of Patent Portfolio to Rapidly Expanding SoftPOS Market
Datametrex Integrates AI to Healthcare To Enhance Efficiencies
Paymetrex Engages Pelent AI to Accelerate Patent Licensing Program
Datametrex Receives $1M Order from Fortune 500 Client
Yönetim: Dong Hyun Shim
CEO
Dong Hyun Shim serves as the CEO of Datametrex AI Limited, leading a team of 21 employees. Information regarding his detailed career history, educational background, and previous roles is not available. His leadership is focused on guiding the company's strategic direction in the AI, technology, and health security sectors. He is responsible for overseeing the development and implementation of Datametrex's AI-driven solutions and expanding its market presence in Canada and South Korea.
Sicil: Due to limited information, specific achievements, strategic decisions, and company milestones under Dong Hyun Shim's leadership cannot be detailed. His tenure and impact on Datametrex's performance require further assessment based on available financial reports and company announcements.
DTMXF OTC Piyasa Bilgileri
The OTC Other tier represents the lowest tier of the OTC market, indicating that Datametrex AI Limited may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be current in their reporting obligations. Investing in OTC Other stocks carries significant risks due to the potential for lack of transparency and regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. This tier is also known as the Pink Open Market.
- OTC Katmanı: OTC Other
- Açıklama Durumu: Unknown
- Limited financial disclosure increases the risk of investing in DTMXF.
- Low liquidity can make it difficult to buy or sell shares at desired prices.
- Higher price volatility due to the OTC listing and small market capitalization.
- Potential for fraud or manipulation due to less regulatory oversight.
- OTC Other tier status indicates the company may not meet minimum financial standards.
- Verify the company's financial reporting status and access available financial statements.
- Assess the trading volume and bid-ask spread to understand liquidity risks.
- Research the company's management team and their track record.
- Review the company's filings and disclosures on the OTC Markets website.
- Consult with a financial advisor to assess the risks and suitability of investing in DTMXF.
- Understand the company's business model and competitive landscape.
- Confirm the legitimacy of the company's operations and assets.
- Operations in Canada and South Korea suggest established business activities.
- Patented AI technology indicates innovation and intellectual property.
- Presence of a CEO and management team suggests organizational structure.
- Provision of health security services indicates engagement with regulated industries.
Yatırımcılar Datametrex AI Limited (DTMXF) Hakkında Ne Soruyor
DTMXF için değerlendirilmesi gereken temel faktörler nelerdir?
Datametrex AI Limited (DTMXF) şu anda yapay zeka skoru 39/100, düşük puanı gösteriyor. Temel güçlü yan: Patented AI technology provides a competitive edge.. İzlenmesi gereken birincil risk: Potential: Intense competition from larger AI and IT service providers.. Bu bir finansal tavsiye değildir.
DTMXF MoonshotScore'u nedir?
DTMXF şu anda MoonshotScore'da 39/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
DTMXF verileri ne sıklıkla güncellenir?
DTMXF fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler DTMXF hakkında ne diyor?
DTMXF için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
DTMXF'a yatırım yapmanın riskleri nelerdir?
DTMXF için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Intense competition from larger AI and IT service providers.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
DTMXF'ın P/E oranı nedir?
DTMXF için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için DTMXF'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
DTMXF aşırı değerli mi, yoksa düşük değerli mi?
Datametrex AI Limited (DTMXF)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
DTMXF'ın temettü verimi nedir?
Datametrex AI Limited (DTMXF) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Limited information available on CEO track record.
- Lack of analyst coverage impacts investment thesis validation.
- OTC market carries inherent risks due to limited regulation and disclosure.